Controversies in Colon Cancer- ctDNA in the Adjuvant Therapy of Colon Cancer and in the Management of Oligometastases (in Favor)
Ahmed Zakari, MD
Addressing Disparities in Access to Supportive Care During Cancer Treatment and Survivorship: An Integrative Approach
Ashwin Mehta, MD, MPH
Cost and Access to Novel Therapeutic Agents? Where Are The Obstacles?
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Cancer Genetic Risk Factors: What’s New and What You Need to Know?
Alexandra Hernandez, MSN, APRN, FNP-C, AOCNP®
